{
  "id": 751,
  "text": "The fifth identified $\\mathrm { R C T ^ { 7 2 8 } }$ , comparing concurrent chemoradiotherapy (CCRT) versus chemotherapy or radiotherapy alone after radical hysterectomy in FIGO stages IB-IIA cervical carcinoma patients, was prematurely closed due to suboptimal accrual and protocol violation.",
  "ChatGPT_query": "Please create a <question> that closely aligns with the provided <text>. Ensure that the <question> is formulated in Chinese and does not explicitly reference the text. You may incorporate specific scenarios or contexts in the <question>, allowing the <text> to serve as a comprehensive and precise answer.\n\n<text>: The fifth identified $\\mathrm { R C T ^ { 7 2 8 } }$ , comparing concurrent chemoradiotherapy (CCRT) versus chemotherapy or radiotherapy alone after radical hysterectomy in FIGO stages IB-IIA cervical carcinoma patients, was prematurely closed due to suboptimal accrual and protocol violation.\n\n<question>: \n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n",
  "ChatGPT_response_0": "在FIGO IB-IIA期宫颈癌患者进行根治性子宫切除术后，临床试验同时进行放化疗（CCRT）可能会提前终止的情况包括：患者招募不足（例如入组患者数量未达预期）以及试验中的方案违规。这些因素会显著影响试验的科学性和结果的可靠性，从而导致试验的提前终止。",
  "query": "在FIGO IB-IIA期宫颈癌患者进行根治性子宫切除术后，什么情况下同时进行放化疗（CCRT）的临床试验可能会提前终止？",
  "ChatGPT_query_a": "You are HuatuoGPT-II, equipped with in-depth knowledge in medicine. Your task is to directly answer the user's <question> in Chinese. In formulating your response, you must thoughtfully reference the <reference text>, ensuring that your reply does not disclose your reliance on <reference text>. Aim to provide a comprehensive and informative response, incorporating relevant insights from <reference text> to best assist the user. Please be cautious to avoid including any content that might raise ethical concerns.\n\n<question>: 在FIGO IB-IIA期宫颈癌患者进行根治性子宫切除术后，什么情况下同时进行放化疗（CCRT）的临床试验可能会提前终止？\n\n<reference text>: The fifth identified $\\mathrm { R C T ^ { 7 2 8 } }$ , comparing concurrent chemoradiotherapy (CCRT) versus chemotherapy or radiotherapy alone after radical hysterectomy in FIGO stages IB-IIA cervical carcinoma patients, was prematurely closed due to suboptimal accrual and protocol violation.\n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n\n<reply>: ",
  "response": "在FIGO IB-IIA期宫颈癌患者进行根治性子宫切除术后，临床试验同时进行放化疗（CCRT）可能会提前终止的情况包括：患者招募不足（例如入组患者数量未达预期）以及试验中的方案违规。这些因素会显著影响试验的科学性和结果的可靠性，从而导致试验的提前终止。"
}